Crossmark

Scientific Considerations for the Review and Approval of First Generic Mometasone Furoate Nasal Suspension Spray in the United States from the Bioequivalence Perspective

Crossref DOI link: https://doi.org/10.1208/s12248-018-0283-9

Published Online: 2019-01-07

Published Print: 2019-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Liu, Qing

Absar, Mohammad

Saluja, Bhawana

Guo, Changning

Chowdhury, Badrul

Lionberger, Robert

Conner, Dale P.

Li, Bing V.
License Information

Text and Data Mining valid from 2019-01-07
More Information

Article History

Received: 11 September 2018

Accepted: 6 December 2018

First Online: 7 January 2019

Compliance with Ethical Standards

:

: This article reflects the views of the author and should not be construed to represent the Food and Drug Administration’s view or policies.

Document is current

Any future updates will be listed below